CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
POMPANO BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, is proud to announce the ...
The American College of Radiology is supporting a call from 10 medical specialty societies and academies urging Cigna Healthcare and UnitedHealthcare to update their coverage policies for peripheral ...
A University of Houston engineering professor is warning that implanted cuff electrodes – widely used in therapy for epilepsy, depression and inflammatory disorders – could trigger unintended nerve ...
Please provide your email address to receive an email when new articles are posted on . Active, percutaneous peripheral nerve stimulation reduced pain scores and opioid requirements without side ...
Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
A University of Houston engineering professor is warning that implanted cuff electrodes – widely used in therapy for epilepsy, depression and inflammatory disorders – could trigger unintended nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results